ApprovalTrail

Drug · DIN 02503107

GLOWSCREEN

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since March 13, 2023; first marketed January 26, 2021.
Drug Identification Number (DIN)
02503107
Company (DIN owner)
Supergoop, LLCSan Antonio, Texas, United States
Schedule
Non-prescription drugs
Dosage form
Lotion
Route
Topical
Therapeutic class (ATC)
Combinations of protectives against uv-radiation D02BA30
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
OCTOCRYLENE10 %W/W
AVOBENZONE3 %W/W
OCTISALATE5 %W/W